Physicochemical Properties
| Molecular Formula | C18H13BRCLN5O3 | 
| Molecular Weight | 462.68 | 
| Exact Mass | 460.989 | 
| Elemental Analysis | C, 46.73; H, 2.83; Br, 17.27; Cl, 7.66; N, 15.14; O, 10.37 | 
| CAS # | 134742-26-0 | 
| PubChem CID | 368696 | 
| Appearance | Solid powder | 
| Density | 1.663g/cm3 | 
| Index of Refraction | 1.708 | 
| LogP | 5.274 | 
| Hydrogen Bond Donor Count | 3 | 
| Hydrogen Bond Acceptor Count | 6 | 
| Rotatable Bond Count | 4 | 
| Heavy Atom Count | 28 | 
| Complexity | 549 | 
| Defined Atom Stereocenter Count | 0 | 
| SMILES | NC1C=CC=CC=1C(NC(NC1C=CC(OC2N=CC(Br)=CN=2)=C(Cl)C=1)=O)=O | 
| InChi Key | LRPFTPYFADHGQJ-UHFFFAOYSA-N | 
| InChi Code | InChI=1S/C18H13BrClN5O3/c19-10-8-22-18(23-9-10)28-15-6-5-11(7-13(15)20)24-17(27)25-16(26)12-3-1-2-4-14(12)21/h1-9H,21H2,(H2,24,25,26,27) | 
| Chemical Name | 2-amino-N-[[4-(5-bromopyrimidin-2-yl)oxy-3-chlorophenyl]carbamoyl]benzamide | 
| Synonyms | NSC-639828; NSC639828; NSC 639828 | 
| HS Tariff Code | 2934.99.9001 | 
| Storage | Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 monthNote: This product requires protection from light (avoid light exposure) during transportation and storage. | 
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) | 
Biological Activity
| Targets | DNA polymerase α | 
| References | [1]. Effect of novel benzoylphenylurea derivatives on DNA polymerase alpha activity using the synthesome-based in vitro model system. Invest New Drugs. 2003;21(4):421-428. | 
Solubility Data
| Solubility (In Vitro) | DMSO : ~100 mg/mL (~216.1 mM) | 
| Solubility (In Vivo) | Solubility in Formulation 1:  ≥ 2.5 mg/mL (5.40 mM) (saturation unknown)  in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) | 
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1613 mL | 10.8066 mL | 21.6132 mL | |
| 5 mM | 0.4323 mL | 2.1613 mL | 4.3226 mL | |
| 10 mM | 0.2161 mL | 1.0807 mL | 2.1613 mL | 
